We recently published 11 Best Cancer Stocks to Buy Right Now. Arcellx, Inc. stands sixth among them. Arcellx, Inc. (NASDAQ:ACLX) is a biotechnology company developing next-generation cell therapies to ...

Gilead Sciences’ twice-yearly injectable HIV-1 capsid inhibitor, Yeytuo receives European marketing authorization: Foster City, California Thursday, August 28, 2025, 12:00 Hrs [ ...

The Ohio District 5 Area Agency on Aging, Inc. is proud to announce that Michael Porter has been named the 2025 Outstanding ...

A federal judge has recused herself from a criminal case involving a scheme to sell counterfeit HIV drugs on the black market ...

Gilead Sciences, Inc. has received the European Commission (EC) marketing authorization for Yeytuo (lenacapavir)-the ...

We recently published Top 10 Trending Stocks to Watch Ahead of Nvidia Earnings. Gilead Sciences Inc (NASDAQ:GILD) is one of ...

The European Commission has granted marketing authorization for Yeytuo (lenacapavir)—Gilead Sciences Inc.’s twice-yearly ...

Gilead Sciences (GILD) stock in focus as its twice-yearly HIV PrEP therapy lenacapavir, is approved in the EU as Yeytuo for HIV prevention. Read more here.

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

In this article, we will take a detailed look at the Top 10 Trending Stocks to Watch Ahead of Nvidia Earnings.

While Gilead Sciences posted a strong Q2 earnings print, GILD stock saw profit-taking. Here's why the red ink could be an ...